Formulation containing a nucleotide analogue
Patent Number: US6130208
Publication date: 2000-10-10
Inventor(s): BROADHEAD JOANNE [GB]
Applicant(s): ASTRAZENECA UK LTD [GB]
Requested Patent: TW585764
Application Number: US19980125165 19980812
Priority Number(s): SE19970002680 19970711; WO1998SE01287 19980629
IPC Classification: A61K31/70
EC Classification: C07H17/08F
Equivalents: AU8362598, BR9810703, CA2295628, CN1263533, EE200000022, EE4119, EP1000079, HU0002622, ID24716, JP2001509512T, NO20000123, NZ502073, PL337970, RU2216330, SK183699, TR200000006T, UA65576, WO9902542, ZA9805669
Abstract
PCT No. PCT/SE98/01287 Sec. 371 Date Aug. 12, 1998 Sec. 102(e) Date Aug. 12, 1998 PCT Filed Jun. 29, 1998 PCT Pub. No. WO99/02542 PCT Pub. Date Jan. 21, 1999A pharmaceutical composition comprising a nucleotide analogue and one or more glass forming additives which is suitable for freeze drying.

Data supplied from the esp@cenet database - l2
Comments: 0
Votes:5